Sai Life Sciences Chooses Dassault ONE Lab For Drug Discovery

Sai Life Sciences, the fastest-growing contract research, development, and manufacturing company in India, has chosen Dassault Systèmes' solutions to boost productivity, improve data quality, and promote collaboration in its research and process development labs, which will hasten the development of new drugs. Sai Life Sciences is utilizing the 3DEXPERIENCE platform-based industrial solution experience 'ONE Lab' from Dassault Systèmes.

The solution, which makes use of BIOVIA software, aids in productivity optimization, ensures data confidentiality and accuracy, and provides easy access to data for analysis. Sai Life Sciences has implemented ‘ONE Lab’ to bolster security measures, and facilitate effortless data access and analysis. Utilizing ‘ONE Lab’, Sai Life Sciences, is creating an integrated digital platform for its R&D and chemistry, manufacturing and controls (CMC) laboratories, effectively tackling some of the most notable challenges ailing the research in this sector, specifically associated with project implementation, as per pharmabiz.

The main goals of this choice are time savings, the promotion of sustainable practices, the elimination of errors, and the creation of a centralized, trustworthy source of information to support multi-stakeholder collaboration spanning research, development, and commercial manufacture. "With Sai Life Sciences, we are attempting to build a brighter future for life sciences and health care research and development in the country. Our long-term vision is to redefine industry standards by combining transformative technology with unwavering commitment. This is not just about optimizing productivity and data quality it is about setting a new benchmark for collaboration and efficiency in the industry. We are not simply innovating; we are shaping the future of research, one breakthrough at a time," said Deepak NG, Managing Director, India, Dassault Systèmes.